Cargando…
Increased serum IL-36γ levels are associated with disease severity in myasthenia gravis patients
BACKGROUND: Interleukin 36 (IL-36), as a gradually recognized cytokine, is involved in the occurrence and evolution of autoimmune diseases. Nevertheless, the relationship between myasthenia gravis (MG) and IL-36 is rarely reported. METHODS: We evaluated the serum levels of IL-36 (IL-36α, IL-36β and...
Autores principales: | Zhang, Qiu-Xia, Li, Yue, Jiang, Shu-Min, Zhang, Lin-Jie, Yi, Ming, Wang, Jing, Qi, Yuan, Yang, Li, Yang, Chun-Sheng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7436949/ https://www.ncbi.nlm.nih.gov/pubmed/32814555 http://dx.doi.org/10.1186/s12883-020-01885-z |
Ejemplares similares
-
Increased serum IL-36β and IL-36γ levels in patients with neuromyelitis optica spectrum disorders: association with disease activity
por: Yang, Chun-Sheng, et al.
Publicado: (2019) -
Low serum albumin concentrations are associated with disease severity in patients with myasthenia gravis
por: Weng, Yi-Yun, et al.
Publicado: (2016) -
Altered Gut Microbiota in Myasthenia Gravis
por: Qiu, Dongxu, et al.
Publicado: (2018) -
Afterdischarges in Myasthenia Gravis
por: Yang, Li, et al.
Publicado: (2021) -
Application of lymphoplasmapheresis in the treatment of severe myasthenia gravis
por: Duan, Weiwei, et al.
Publicado: (2022)